Methods for the Selection of Subjects for Multiple Sclerosis Therapy
Pharmalicencing Fri, 01 Sep 2006 11:04 AM PDT
Multiple Sclerosis (MS) is a life-long chronic autoimmune disease diagnosed primarily in young adults who have a virtually normal life expectancy. Estimates place the annual costs of MS in the United States in excess of $2.5 billion.

Let's not be too hasty Times Online Fri, 01 Sep 2006 2:59 PM PDT For all the medical excitement about stem cells, scientists accept that their potential for treating conditions such as multiple sclerosis (MS) and diabetes lies in the future. With a few exceptions, chiefly leukaemia, it will be years before stem-cell therapies are ready for clinical use.

Scientists Identify Compounds With Potential in Neurological Disorders
RedNova Fri, 01 Sep 2006 12:18 PM PDT
Scientists at Harvard University have identified key compounds that stimulate stem cell growth in the brain which may one day lead to restored function for people affected by Parkinson's disease, strokes, multiple sclerosis, and a wide range of neurological disorders.